[Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].
Zhonghua Yu Fang Yi Xue Za Zhi
; 56(2): 103-107, 2022 Feb 06.
Article
in Chinese
| MEDLINE | ID: covidwho-1600048
ABSTRACT
Influenza is an infectious respiratory disease caused by the influenza viruses. Older people, infants and people with underlying medical conditions could have a higher risk of severe influenza symptoms and complications. The co-infection of Coronavirus Diseases 2019 (COVID-19) with influenza viruses could lead to the complication of prevention, diagnosis, control, treatment, and recovery of COVID-19. Influenza vaccine and COVID-19 vaccine overlapped in target populations, vaccination time, and inoculation units. Although there was insufficient evidence on the immunogenicity and safety of co-administration of influenza vaccine and COVID-19 vaccine, World Health Organization and some countries recommended co-administration of inactivated influenza vaccine and COVID-19 vaccine. This review summarized domestic and international vaccination policies and research progress, and put forward corresponding suggestions in order to provide scientific support for the formulation of vaccination strategy on seasonal influenza vaccine and COVID-19 vaccine.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Influenza Vaccines
/
Influenza, Human
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Aged
/
Humans
/
Infant
Country/Region as subject:
Asia
Language:
Chinese
Journal:
Zhonghua Yu Fang Yi Xue Za Zhi
Year:
2022
Document Type:
Article
Affiliation country:
Cma.j.cn112150-20211203-01117
Similar
MEDLINE
...
LILACS
LIS